• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Ligand Pharmaceuticals (LGND)

Common Shares
Sell: $295.00|Buy: $328.88|Change: 5.42 (1.71%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.

Address

3911 Sorrento Valley Boulevard
Suite 110
San Diego
CA
USA
92121

Telephone

+1 858 5507500

Website

https://www.ligand.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Ligand Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20272027-10-29T08:30:00
Ligand Pharmaceuticals Inc Third Quarter Earnings Results for 20272027-10-29T00:00:00
Ligand Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20272027-08-06T08:30:00
Ligand Pharmaceuticals Inc Second Quarter Earnings Results for 20272027-08-06T00:00:00
Ligand Pharmaceuticals Inc Annual General Meeting for 20272027-06-04T11:30:00
Ligand Pharmaceuticals Inc First Quarter Earnings Conference Call for 20272027-05-07T08:30:00
Ligand Pharmaceuticals Inc First Quarter Earnings Results for 20272027-05-07T00:00:00
Ligand Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20262027-02-26T08:30:00
Ligand Pharmaceuticals Inc Fourth Quarter Earnings Results for 20262027-02-26T00:00:00
Ligand Pharmaceuticals Inc Annual Report for 20262027-02-26T00:00:00
Ligand Pharmaceuticals Investor Day2026-12-08T10:30:00

Previous key dates

NameKey Date
Ligand Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20262026-10-29T08:30:00
Ligand Pharmaceuticals Inc Third Quarter Earnings Result for 20262026-10-29T00:00:00
H.C. Wainwright 28th Annual Global Investment Conference2026-09-14T10:00:00
Citi 2026 Biopharma Back to School Conference2026-09-10T09:20:00
Wells Fargo Healthcare Conference 20262026-09-08T12:45:00
Ligand Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20262026-08-06T08:30:00
Ligand Pharmaceuticals Inc Second Quarter Earnings Result for 20262026-08-06T00:00:00
Ligand Pharmaceuticals Inc Annual General Meeting for 20262026-06-05T11:30:00
Ligand Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-05-07T08:30:00
Ligand Pharmaceuticals Inc First Quarter Earnings Result for 20262026-05-07T00:00:00
Nordic-American Healthcare Conference 20262026-03-25T15:45:00
38th Annual ROTH Conference2026-03-23T13:00:00
Ligand Pharmaceuticals Inc Annual Report for 20252026-02-27T00:00:00
Ligand Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-26T08:30:00
Ligand Pharmaceuticals Inc Fourth Quarter Earnings Result for 20252026-02-26T00:00:00
Oppenheimer 36th Annual Healthcare Life Sciences Conference2026-02-25T10:00:00
Investor Day2025-12-09T10:30:00
Ligand Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-11-06T08:30:00
Ligand Pharmaceuticals Inc Third Quarter Earnings Result for 20252025-11-06T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.